[go: up one dir, main page]

AU2003240080A1 - Therapeutic conjugate consisting of a mek inhibitor and a targeting agent - Google Patents

Therapeutic conjugate consisting of a mek inhibitor and a targeting agent

Info

Publication number
AU2003240080A1
AU2003240080A1 AU2003240080A AU2003240080A AU2003240080A1 AU 2003240080 A1 AU2003240080 A1 AU 2003240080A1 AU 2003240080 A AU2003240080 A AU 2003240080A AU 2003240080 A AU2003240080 A AU 2003240080A AU 2003240080 A1 AU2003240080 A1 AU 2003240080A1
Authority
AU
Australia
Prior art keywords
targeting agent
mek inhibitor
therapeutic conjugate
conjugate consisting
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003240080A
Other languages
English (en)
Inventor
Michael Ting Bong Ho
Kevin Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Biotechnology Ltd
Original Assignee
Cambridge Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biotechnology Ltd filed Critical Cambridge Biotechnology Ltd
Publication of AU2003240080A1 publication Critical patent/AU2003240080A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003240080A 2002-06-11 2003-06-11 Therapeutic conjugate consisting of a mek inhibitor and a targeting agent Abandoned AU2003240080A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0213383.3A GB0213383D0 (en) 2002-06-11 2002-06-11 Therapeutic conditions
GB0213383.3 2002-06-11
PCT/GB2003/002501 WO2003103717A1 (fr) 2002-06-11 2003-06-11 Conjugue therapeutique compose d'un inhibiteur de la mek et d'un agent de ciblage

Publications (1)

Publication Number Publication Date
AU2003240080A1 true AU2003240080A1 (en) 2003-12-22

Family

ID=9938360

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003240080A Abandoned AU2003240080A1 (en) 2002-06-11 2003-06-11 Therapeutic conjugate consisting of a mek inhibitor and a targeting agent

Country Status (3)

Country Link
AU (1) AU2003240080A1 (fr)
GB (1) GB0213383D0 (fr)
WO (1) WO2003103717A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114788867A (zh) * 2022-04-24 2022-07-26 天津医科大学总医院 Map2k1作为化疗后神经痛的治疗靶点的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6510094A (en) * 1993-04-16 1994-11-08 University Of Portsmouth Enterprise Limited Drug delivery system
GB9721189D0 (en) * 1997-10-08 1997-12-03 Speywood Lab The Limited Analgesic conjugates
WO2000056706A1 (fr) * 1999-03-19 2000-09-28 Du Pont Pharmaceuticals Company Amino-thio-acrylonitriles utilises comme inhibiteurs des kinases mek
CA2362705A1 (fr) * 1999-03-19 2000-09-28 Joseph B. Santella, Iii N-adamant-1-yl-n'-¬4-chlorobenzothiazol-2-yl| uree utilisee dans le traitement des inflammations et comme agent de radiosensibilisation anticancereux
GB9907429D0 (en) * 1999-03-31 1999-05-26 Microbiological Res Authority Modulation of C-fibre activity
CN1358094A (zh) * 1999-07-16 2002-07-10 沃尼尔·朗伯公司 用mek抑制剂治疗慢性疼痛的方法
US20020054869A1 (en) * 2000-09-01 2002-05-09 Han-Mo Koo Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma

Also Published As

Publication number Publication date
WO2003103717A1 (fr) 2003-12-18
GB0213383D0 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
AU2003291354A1 (en) Methods and compostions for therapeutic use of rna interference
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003303199A1 (en) Generation of efficacy, toxicity and disease signatures and methods of use thereof
AU2003261251A1 (en) Methods of delivering therapeutic agents
AU2001269046A1 (en) Use of therapeutic benzamide derivatives
AU2003241833A1 (en) Beta-ALANINE DERIVATIVE AND USE THEREOF
AU2002952993A0 (en) Therapeutic and diagnostic agents
AU2003287354A1 (en) An intracardiac catheter and method of use
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2002258600A1 (en) Uses of targeted oxidative therapeutic formulation in arteriosclerosis
AU2003232148A1 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
AU2001242985A1 (en) New combination of a betablocker and a cholesterol-lowering agent
AU2003299815A1 (en) Matriptase inhibitors and methods of use
AU2003251513A1 (en) Rsk inhibitors and therapeutic uses thereof
AU1490801A (en) Targeted delivery of therapeutic and diagnostic moieties
AU2003240080A1 (en) Therapeutic conjugate consisting of a mek inhibitor and a targeting agent
IL165725A0 (en) Immunotoxin as a therapeutic agent and uses thereof
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003240052A1 (en) Il-11 derivatives and therapeutic uses thereof
AU2003303625A1 (en) Combination of reboxetine and a cyclooxygenase-2 inhibitor
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2002312442A1 (en) Manufacture and use of a herbicide formulation
AU2003253424A1 (en) Generator arrangement and use of a generator arrangement
AU2003267475A1 (en) Tumor targeting agents and uses thereof
AU2003235665A1 (en) Diagnostic and therapeutic uses of topors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase